Technical Service Need help? Our team of experienced experts is here for you with full support.
AKA-50
Galantamine Hydrobromide
Cat. No.
AKA-50
CAS No.
1953-04-4
MF
C17H22BrNO3
MW
368.2654
Galanthamine hydrobromide is a selective, reversible, competitive, alkaloid AChE inhibitor.
Advanced Equipments & Extensive Production Expertise
Commercial Manufacturing
Stable Quality
Customization Supporting
Technical Service 
86-28-85159085 
info@aktin.com
Technical Data
Description
Storage and Shipping
References
Product Name
Galantamine Hydrobromide
CAS No.
1953-04-4
MF
C17H22BrNO3
MW
368.2654
Specification
Pharmaceutical Grade
Research Area
Alzheimer
Description
Galanthamine hydrobromide is a selective, reversible, competitive, alkaloid AChE inhibitor. Packing: 10mg, 20mg, 50mg, 100mg, 500mg, 1g, 5g, 10g, 1kg Availability: Research and Bulk Quantity
Documents
Certificate of Analysis (COA), API specification, Safety Data Sheet (SDS/MSDS), evidence of GMP compliance, Stability data / Stability summary, etc.
Storage and Shipping
Store in a cool & dry place, keep away from strong light and heat.
References
[1]. Ji YW, et al. Plasticity in ventral pallidal cholinergic neuron-derived circuits contributes to comorbid chronic pain-like and depression-like behaviour in male mice. Nature Communications. 2023 Apr 17;14(1):2182. PMID: 37069246.
[2]. Han Y, et al. α4 nicotinic receptors on GABAergic neurons mediate a cholinergic analgesic circuit in the substantia nigra pars reticulata. Acta Pharmacologica Sinica. 2024 Jun;45(6):1160-1174. PMID: 38438581.
[3]. Saito T, et al. Early administration of galantamine from preplaque phase suppresses oxidative stress and improves cognitive behavior in APPswe/PS1dE9 mouse model of Alzheimer's disease. Free Radical Biology & Medicine. 2019 Dec;145:20-32. PMID: 31536772.
[2]. Han Y, et al. α4 nicotinic receptors on GABAergic neurons mediate a cholinergic analgesic circuit in the substantia nigra pars reticulata. Acta Pharmacologica Sinica. 2024 Jun;45(6):1160-1174. PMID: 38438581.
[3]. Saito T, et al. Early administration of galantamine from preplaque phase suppresses oxidative stress and improves cognitive behavior in APPswe/PS1dE9 mouse model of Alzheimer's disease. Free Radical Biology & Medicine. 2019 Dec;145:20-32. PMID: 31536772.
Disclaimer
This product is intended solely for scientific research or regulatory filing purposes. We do not provide products or services to individuals, please strictly comply with all applicable laws, regulations, and the committed use. Use for any other purpose is strictly prohibited.
Related Products
AKA-384
Tedizolid phosphate
CAS No.: 856867-55-5
MF:C17H16FN6O6P
AKA-383
Brivaracetam
CAS No.:357336-20-0
MF:C11H20N2O2
AKA-382
Cobimetinib Fumarate
CAS No.:1369665-02-0
MF:C46H46F6I2N6O8
AKA-379
Bempedoic acid
CAS No.:738606-46-7
MF:C19H36O5
AKA-378
Borofalan(10B)
CAS No.:80994-59-8
MF:C9H12BNO4
AKA-377
AkProva™ Metildigoxin
CAS No.:30685-43-9(acetone-free)
MF:C42H66O14.1/2C3H6O
AKA-376
AkProva™ beta-Acetyldigoxin
CAS No.:5355-48-6
MF:C43H66O15
AKA-375
Ak-NucleoVia™ Agrostemmoside E
CAS No.:2656438-29-6
MF:C84H128O45
AKA-374
Novobiocin sodium
CAS No.:1476-53-5
MF:C31H35N2NAO11
AKA-360
Travoprost
CAS No.:157283-68-6
MF:C26H35F3O6
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.
